Skip to main content

Definition und pathophysiologische Grundlagen der Steroidresistenz

  • Conference paper
Das therapieresistente Asthma
  • 20 Accesses

Zusammenfassung

Asthma ist eine chronisc he Entzündungserkrankung, die durch eine variable Atemwegsobstrukt ion und einer bronchialen Hyperreaktivität charakterisiert ist.

Die inflammatorische Aktivität spielt eine wesentliche Rolle bei der Evolution des Asthma bronchiale und ist in der Regel auf eine antiintflammatorische Therapie wie Kortison empfindlich.

Ein Großteil der Patienten spricht auf diese Medikation sehr gut an, jedoch ist eine Abnahme der Kortisonwirkung bei langjähriger Therapie moglich, wie es auch Hinweise gibt, daß eine fehlende Ansprechbarkeit auf Gluk okortikoide angeboren sein kann.

Es gibt mehrere Mechanismen, die eine Kortisonresistenz bewirken können. Die Diagnose einer fehlenden Empfindlichkeit von Kortison ist insofern von großer Bedeutung, da durch die Darstellung der molekularen Mechanismen dieses Phänomens ein besseres Verständnis der Kortisonwirkung und der Pathophysiologie des Asthmas erlangt werden kann.

Eine fehlende Ansprechbarkeit auf Kortison kann sowohl klinisch, als auch anhand von Laboruntersuchun gen diagnostiziert werden. Der folgende Review beschreibt die molekularbiologischen Aktivitaten einer Kortisonresistenz beim Asthma bronchiale und wie Kortikoide eine chronische Inflammation supprimieren können.

Summary

Asthma is a chronic respiratory disease characterized by reversible airflow limitation and airway responsiveness to a variety of stimuli.

Airway inflammation is thought to play a significant role in the above process.

These components of asthma are all responsive to corticosteroids which inhibit airway inflammation and immune response, and seems to attenuate airway responsiveness.

Most patients respond favourably to conventional therapy, however, resistance to the antiinflammatory presents a management problem.

There may be several mechanisms for resistance to the effects of glucocorticoids, and it is important to characterize patients with steroid resistance carefully which may provide new insights into the mechanisms of steroid action as well as the underlying chronic disease process.

Corticoid responsiveness can be assessed clinically and also in terms of cellular responsiveness with regard to both local and circulating inflammatory cells.

This review will present concepts of the molecular basis of glucocorticoid resistance in asthma and how glucocorticoids suppress chronic inflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 29.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 39.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. Barnes PJ, Adcock IM (1995) Steroid resistance in asthma. Q J Med 88: 455-68

    CAS  Google Scholar 

  2. Szefler SJ, Leung DYM (1997) Glucocorticoid-resistant asthma: pathogenesis and clinical implication for management. Eur Respir J 10: 1640-47

    Article  PubMed  CAS  Google Scholar 

  3. Sher ER, Leung DYM, Surs W et al (1994) Steriod-resistant asthma: cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest 93: 33-9

    Article  PubMed  CAS  Google Scholar 

  4. Barnes PJ, Greening AP, Crompton GK (1995) Glucocorticoid resistance in asthma. Am J Respir Crit Care Med 152: 125-142

    Google Scholar 

  5. Vecchiarelli A, Siracusa A, Cenci E, Puliti M, Abbritti G (1992) Effect of corticosteroid treatment on interleukin-1 and tumour necrosis factor secretion by monocytes from subjects with asthma. Clin Exp Allergy 22: 365-70

    Article  PubMed  CAS  Google Scholar 

  6. Corrigan J, Brown PH, Barnes NC, Tsai J-J, Frew AJ, Kay AB (1991) Glucocorticoid resistance in chronic asthma. Am J Respir Dis 144: 1016-25

    Article  CAS  Google Scholar 

  7. Brown PH, Teelucksingh S, Matusiewicz SP, Greening AP, Crompton GK, Edwards CRW (1991) Cutaneous vasoconstrictor response to glucocorticoids in asthma. Lancet 337: 576-80

    Article  PubMed  CAS  Google Scholar 

  8. Leung DYM, Martin RJ, Szefler Si (1995) Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J Exp Med 181: 33-40

    Article  PubMed  CAS  Google Scholar 

  9. Naseer T, Minshall EM, Leung DY, Laberge S, Ernst P, Martin RJ, Hound Q (1997) Expression of interleukin 12 and interleukin 13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med 155: 845-851

    PubMed  CAS  Google Scholar 

  10. Adcock IM, Gilbey T, Gelder CM, Chung KF, Barnes Pi (1996) Glucocorticoid receptor localization in normal and asthmatic lung. Am J Respir Crit Care Med 154: 771-82

    PubMed  CAS  Google Scholar 

  11. Chung KF (1998) Corticosteroid responsiveness and the evolution of asthma. Clin Exp Allergy 28 [Suppl. 51: 69-75

    Google Scholar 

  12. Chronsos GP, Vingerhoeds A, Brandon D (1982) Primary cortisol resistance in man: a glucocorticoid receptor-mediated disease. J Clin Invest 69: 1261-1269

    Article  Google Scholar 

  13. Adcock IM, Lane SJ, Brown CR, Peters MJ, Lee TH, Barnes PJ (1995) Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma. J Immunol 154: 3500-5

    PubMed  CAS  Google Scholar 

  14. Hurley DM, Accili D, Stratakis CA (1991) Point mutation cansing a single amion acid substitution in the hormone-binding domain of the glucocorticoid receptor in familiae glucocorticoid resistance. J Clin Invest 87: 680-686

    Article  PubMed  CAS  Google Scholar 

  15. Spahn JD, Leung DY, Surs W, Harbeck RJ, Nimmagadda S, Szefler SJ (1995) Reduced glucocorticoid binding affinity in asthma is related to Definition und pathophysiologische Grundlagen der Steroidresistenz 13 ongoing allergic inflammation. Am J Respir Crit Care Med 151: 1709-14

    PubMed  CAS  Google Scholar 

  16. Nimmagadda SR, Szefler SJ, Spahn JD, Surs W, Leung DY (1997) Allergen exposure decreases glucocorticoid receptor binding affinity and steroid responsiveness in atopic asthmatics. Am J Respir Crit Care Med 155: 87-93

    PubMed  CAS  Google Scholar 

  17. Kam J, Szefler SJ, Surs W, Sher E, Leung DYM (1993) The combined effects of interleukin 2 and interleukin 4 alter the binding affinity of the glucocorticoid receptor. J Immunol 151: 3460-3466

    PubMed  CAS  Google Scholar 

  18. Munck A, Mendee DB, Smitz LI, Orti E (1990) Glucocorticoid receptors and actions. Am Rev Respir Dis 1412: 2-10

    Google Scholar 

  19. Truss M, Beato M ((1993) Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocrine Rev 14: 459-479

    CAS  Google Scholar 

  20. Yang Yen HF, Chambord JC, Sun YL (1990) Transcriptional interference between c-Jun and the glucocorticoid receptor inhibition of DNA-binding due to indirect protein interaction. Cell 62: 1205-12015

    Article  PubMed  CAS  Google Scholar 

  21. Klemm DJ, Surs W, Spalin JD, Szefler SJ, Leung DYM (1996) Alterations in glucocorticoid receptor-binding to DNA contributes to steroid asthma. J Allergy Clin Immunol 97: 716A

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Wien

About this paper

Cite this paper

Pohl, R.W. (2000). Definition und pathophysiologische Grundlagen der Steroidresistenz. In: Kummer, F., Kneußl, M. (eds) Das therapieresistente Asthma. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6335-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6335-1_1

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-83401-5

  • Online ISBN: 978-3-7091-6335-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics